Galvanizing Health Equity Through Novel and Diverse Educational Resources (GENDER) Research Education R25 (R25 Clinical Trial Not Allowed) (RFA-OD-22-015) Application due date: June 27, 2023
Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required) (PAR-23-170) Earliest application submission date: September 5, 2023 Application due date: October 5, 2023
Investigator-Initiated Research in Genomics and Health Equity (R01 Clinical Trial Optional) (RFA-HG-23-017) Letter of intent due date 30 days prior to the application receipt date. Earliest application submission date: October 8, 2023 Application due date: November 8, 2023
Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial Optional) (RFA-HG-23-018) Letter of intent due date 30 days prior to the application receipt date. Earliest application submission date: October 8, 2023 Application due date: November 8, 2023
Notice of Special Interest (NOSI): Research to Improve Pre-Pregnancy Care and Enhance Healthy Birth Intervals (NOT-HD-23-003) Applications will be accepted through September 8, 2024.
NOSI: Administrative Supplements to Promote Research Continuity and Retention of NIH Mentored Career Development (K) Award Recipients and Scholars (NOT-OD-23-031) Submission dates vary by awarding ICO.
NOSI: Administrative Supplement for Continuity of Biomedical and Behavioral Research Among First-Time Recipients of NIH Research Project Grant Awards (NOT-OD-23-032) Submission dates vary by awarding ICO.
Additional Funding Opportunities
|